Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

17.02
+0.37002.22%
Pre-market: 17.090.0695+0.41%07:37 EDT
Volume:8.64M
Turnover:146.44M
Market Cap:19.56B
PE:-48.03
High:17.05
Open:16.75
Low:16.67
Close:16.65
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:1.04
T/O Rate:0.76%
Dividend:0.48
Dividend Rate:2.82%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.37
PE(LYR):-5.67

Loading ...

Viatris Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
May 16

Viatris shareholders approved 2025 executive pay in advisory vote at annual meeting

Reuters
·
May 16

Viatris Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
May 14

Viatris (VTRS) Is Up 10.6% After Q1 Beat, CFO Change And Outlook Reaffirmation - What's Changed

Simply Wall St.
·
May 13

Viatris Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
May 12

UBS Adjusts Viatris Price Target to $23 From $20

MT Newswires Live
·
May 11

Viatris Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
May 09

Viatris Is Maintained at Buy by Truist Securities

Dow Jones
·
May 09

Viatris price target raised to $20 from $18 at Truist

TIPRANKS
·
May 08

Viatris (VTRS) Heavy FY 2025 Losses Keep Bullish Turnaround Narratives Under Pressure

Simply Wall St.
·
May 08

Viatris to present at Bank of America Securities Healthcare Conference

Reuters
·
May 08

Viatris Inc. Stock Rises 9.0%, Outperforms Market

Dow Jones
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

Stock Track | Viatris Soars 5.27% in Pre-market on Q1 Earnings Beat Driven by China Strength

Stock Track
·
May 07

Viatris Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Viatris beats first-quarter estimates on China strength, branded drug sales

Reuters
·
May 07

Viatris Exec Says Co Expects Mid to High Single Digit Revenue Growth in Greater China in 2026 -Conf Call

THOMSON REUTERS
·
May 07

Ireland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth

Reuters
·
May 07

Theravance Biopharma Q1 net loss narrows to $4.93 million; revenue rises 15% to $17.7 million

Reuters
·
May 07

GUIDANCE: (VTRS) Viatris Expects 2026 Adjusted EPS Range $2.33 - $2.47, vs. FactSet Est of $2.44

MT Newswires Live
·
May 07